CLSI C56-A

CLSI C56-A

Click here to purchase
Clinical and Laboratory Standards Institute document C56-A – Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicatorsof Interference in Clinical Laboratory Analysis; Approved Guideline focuses on the intended usefulness and challenging issues ofhemolysis, icterus, and lipemia/turbidity (HIL) indices as estimates of interference that may impact the validity and clinical utilityof reportable patient results. C56 is closely aligned with CLSI document EP071; thus, the basic concepts for interference testingare briefly discussed in C56 to gain an understanding of the process by which HIL alert indices are established. Automated HILsystems currently available from various manufacturers are also described. This document enhances the continuous education ofhealth care personnel by explaining the mechanisms of HIL interference, which in some cases include the noncorrelation ofvisual and (semi)quantitative HIL indices, the strengths and limitations of HIL measurements, and the verification of HIL indicesin the clinical laboratory.

Product Details

Published:
07/01/2012
ISBN(s):
1562387995
Number of Pages:
64
File Size:
1 file , 1.9 MB

You may also like

CLSI VET01S

CLSI VET01S

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 6th Edition, VET01SEd6Estandard by Clinical and...

CLSI EP33

CLSI EP33

Use of Delta Checks in the Medical Laboratory, 2nd Edition, EP33Ed2Estandard by Clinical and Laboratory Standards Institute, 06/01/2023

CLSI EP25-Ed2

CLSI EP25-Ed2

Evaluation of Stability of In Vitro Medical Laboratory Test Reagents, 2nd Edition, EP25Ed2Estandard by Clinical and Laboratory Standards Institute, 04/26/2023

CLSI PRE04

CLSI PRE04

Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations, 1st Edition, PRE04Ed1Estandard by Clinical and Laboratory Standards...

Back to Top